PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsBridgebio Pharma
Bridgebio Pharma(BBIO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Acoramidis
healthy volunteers/patients
,
covid-19
,
amyloidosis
,
cardiomyopathies
,
polyneuropathies
,
familial amyloid neuropathies
,
heart diseases
,
amyloid neuropathies
,
familial amyloidosis
Alfacalcidol
healthy volunteers/patients
,
renal cell carcinoma
,
carcinoma
,
muscular atrophy
,
spinal muscular atrophy
,
melanoma
,
neoplasms
,
uterine cervical neoplasms
,
anemia
,
chronic hepatitis d
,
hepatitis d
,
rheumatoid arthritis
,
arthritis
,
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis
Aspartame
human influenza
Retinol
lung diseases
,
mycobacterium avium complex
,
bronchiectasis
,
mycobacterium avium-intracellulare infection
,
mycobacterium infections
Globulin, immune
neoplasms
,
lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
breast neoplasms
Alxn2060
healthy volunteers/patients
,
cardiomyopathies
,
amyloidosis
,
heart diseases
,
polyneuropathies
,
familial amyloid neuropathies
,
familial amyloidosis
VT30
congenital abnormalities
,
vascular malformations
,
lymphangioma
,
lymphatic abnormalities
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use